Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8023850rdf:typepubmed:Citationlld:pubmed
pubmed-article:8023850lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8023850lifeskim:mentionsumls-concept:C0178443lld:lifeskim
pubmed-article:8023850lifeskim:mentionsumls-concept:C0206307lld:lifeskim
pubmed-article:8023850lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:8023850pubmed:issue1lld:pubmed
pubmed-article:8023850pubmed:dateCreated1994-7-29lld:pubmed
pubmed-article:8023850pubmed:abstractTextCanavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA). Sixty-four probands were analyzed for mutations in the ASPA gene. Three point mutations--693C-->A, 854A-->C, and 914C-->A--were identified in the coding sequence. The 693C-->A and 914C-->A base changes, resulting in nonsense tyr231-->ter and missense ala305-->glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies. The 854A-->C transversion converted glu to ala in codon 285. The glu285-->ala mutant ASPA has 2.5% of the activity expressed by the wild-type enzyme. A fourth mutation, 433 --2(A-->G) transition, was identified at the splice-acceptor site in intron 2. The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA. Of the 128 unrelated Canavan chromosomes analyzed, 88 were from probands of Ashkenazi Jewish descent. The glu285-->ala mutation was predominant (82.9%) in this population, followed by the tyr231-->ter (14.8%) and 433 --2(A-->G) (1.1%) mutations. The three mutations account for 98.8% of the Canavan chromosomes of Ashkenazi Jewish origin. The ala305-->glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60% of the 40 mutant chromosomes. Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes.lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:languageenglld:pubmed
pubmed-article:8023850pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:citationSubsetIMlld:pubmed
pubmed-article:8023850pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8023850pubmed:statusMEDLINElld:pubmed
pubmed-article:8023850pubmed:monthJullld:pubmed
pubmed-article:8023850pubmed:issn0002-9297lld:pubmed
pubmed-article:8023850pubmed:authorpubmed-author:MatalonRRlld:pubmed
pubmed-article:8023850pubmed:authorpubmed-author:MichalsKKlld:pubmed
pubmed-article:8023850pubmed:authorpubmed-author:Kan?HHlld:pubmed
pubmed-article:8023850pubmed:authorpubmed-author:ZisV PVPlld:pubmed
pubmed-article:8023850pubmed:authorpubmed-author:BalamuruganKKlld:pubmed
pubmed-article:8023850pubmed:authorpubmed-author:PetroskyAAlld:pubmed
pubmed-article:8023850pubmed:authorpubmed-author:AloyaMMlld:pubmed
pubmed-article:8023850pubmed:issnTypePrintlld:pubmed
pubmed-article:8023850pubmed:volume55lld:pubmed
pubmed-article:8023850pubmed:ownerNLMlld:pubmed
pubmed-article:8023850pubmed:authorsCompleteYlld:pubmed
pubmed-article:8023850pubmed:pagination34-41lld:pubmed
pubmed-article:8023850pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:meshHeadingpubmed-meshheading:8023850-...lld:pubmed
pubmed-article:8023850pubmed:year1994lld:pubmed
pubmed-article:8023850pubmed:articleTitleCanavan disease: mutations among Jewish and non-Jewish patients.lld:pubmed
pubmed-article:8023850pubmed:affiliationResearch Institute, Miami Children's Hospital, FL 33155.lld:pubmed
pubmed-article:8023850pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8023850pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:443entrezgene:pubmedpubmed-article:8023850lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8023850lld:pubmed